| Financial Year |
March 31 2019 |
| Monetary Funds |
9,390,377,662.76 |
| Held-for-trading Financial Assets |
11,777,081,500.34 |
| Notes Receivable |
642,037,271.40 |
| Accounts Receivable |
1,346,760,261.47 |
| Advances to Suppliers |
373,239,985.38 |
| Other Receivables |
413,725,177.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
76,744,975.64 |
| Dividend Receivable |
4,634,867.18 |
| Inventories |
891,528,342.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,527,106,821.86 |
| Other Current Assets |
219,112,175.81 |
| Total Current Assets |
27,581,115,255.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,492,683,088.33 |
| Investment Properties |
-- |
| Fixed Assetes |
1,377,345,841.13 |
| Under-construction Projects |
145,857,653.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
410,025,883.58 |
| R&D expenses |
-- |
| Goodwill |
868,355,316.83 |
| Long-Term Deferred and Prepaid Expenses |
78,680,189.14 |
| Deferred Income Tax Assets |
593,687,375.76 |
| Other Non-Current Assets |
20,400,000.00 |
| Sub-Total of Non-Current Assets |
9,447,640,229.36 |
| Total Assets |
37,028,755,485.26 |
| Short-Term Loans |
2,111,657,200.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
-- |
| Accounts Received In Advance |
566,497,956.91 |
| Employee Compensation Payable |
2,740,342,939.05 |
| Taxes Payable |
401,322,128.31 |
| Interest Payable |
118,992,828.49 |
| Dividend Payable |
7,614,811.22 |
| Other payables |
602,784,013.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,798,421,442.98 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
12,403,390,123.96 |
| Long-term Loans |
80,123,220.27 |
| Bonds Payable |
3,134,505,367.54 |
| Long-Term Accounts Payable |
50,225,288.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
44,178,738.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,379,058,268.71 |
| Total Liabilities |
15,782,448,392.67 |
| Paid-In Capital(Or Share Stock) |
704,130,000.00 |
| Capital Surplus |
1,893,375,128.61 |
| Surplus Reserve |
1,277,988,400.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,172,224,709.28 |
| Minority Stockholder's Interest |
12,709,519,098.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,536,787,994.47 |
| Owner's Equity（Stockholder's Equity） |
21,246,307,092.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,028,755,485.26 |
